Table 5 presents Spearman correlations between visual symptoms and performance on the psychometric task in patients with VSS. There was a strong correlation between scores on the Palinopsia-II scale (TTP) and duration thresholds for small and medium-size gratings (small: rho = 0.72, uncorrected
P = 0.0004; medium: rho = 0.63, uncorrected
P = 0.0012; both correlations survived Bonferroni correction for multiple comparisons). As illustrated in
Figure 4, patients with VSS with TTP had lower duration thresholds compared to those patients with VSS who experienced less or no TTP symptoms.
To investigate differences in duration thresholds between control participants and patients with VSS with and without TTP, we performed Kruskal-Wallis ANOVA with three groups: Control, TTP+ (patients with VSS with TTP scores 4–5), and TTP– (patients with VSS with TTP score 1). The pattern of group differences was consistent across all stimulus sizes (
Fig. 5), highlighting the unexpected finding that TTP appeared to compensate for the attenuated motion direction sensitivity observed in patients with VSS without TTP.
There was a significant effect of group on duration thresholds: χ2 (df = 2) = 10.9, P = 0.004 for small; χ2 (df = 2) = 10.9, P = 0.006 for medium; and χ2 (df = 2) = 6.1, P = 0.046 for large stimuli. TTP– patients had higher thresholds than the healthy controls for small (Z = 2.75, P = 0.006, Cohen's r = 0.46), medium (Z = 2.78, P = 0.006, Cohen's r = 0.47), and large stimuli (Z = 2.78, P = 0.006, Cohen's r = 0.52). TTP+ patients had lower thresholds than TTP– for small (Z = 3.1, P = 0.0019, Cohen's r = 0.78), medium (Z = 2.68, P = 0.007, Cohen's r = 0.67), and large stimuli (Z = 2.71, P = 0.007, Cohen's r = 0.75). However, no significant differences were found between controls and TTP+ for small (Z = 1.04, P = 0.30, Cohen's r = 0.18), medium (Z = 1.10, P = 0.27, Cohen's r = 0.19), or large stimuli (Z = 0.28, P = 0.78, Cohen's r = 0.05).
For SSI, the effect of group was not significant (χ2 (df = 2) = 2.4, n = 37, P = 0.30, η2 = 0.067), indicating that spatial suppression was equally robust in patients with VSS compared to controls, regardless of the presence or absence of TTP.
Notably, whereas the duration thresholds in patients with VSS were related to TTP scores, they remained within the range of variation observed in control subjects. Specifically, participants without TTP had thresholds overlapping with the higher end of the normal range, while those with TTP aligned with the lower end. The only exception was a patient with VSS without TTP (scored “2” on the trailing-type palinopsia scale), who had an extremely high perceptual duration threshold for small-size gratings (see
Fig. 3).
Given the significant effect of gender on duration thresholds (with shorter thresholds in male subjects), we examined the male-to-female ratio in the groups of subjects who scored “5” and “1” on the TTP scale. Among the patients who scored “5,” there were two male patients and two female patients. Among the patients who scored “1,” there were three male patients and five female patients. We also calculated correlations with TTP scores separately for male patients and female patients. All correlations were negative and, in the case of small gratings, significant in both male patients and female patients (
P < 0.05, uncorrected for multiple comparisons, see
Supplementary Results).